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Abstract
We give a scenario-based treatment plan optimization formulation that is equiv-
alent to planning with geometric margins if the scenario doses are calculated
using the static dose cloud approximation. If the scenario doses are instead
calculated more accurately, then our formulation provides a novel robust plan-
ning method that overcomes many of the difficulties associated with previous
scenario-based robust planning methods. In particular, our method protects
only against uncertainties that can occur in practice, it gives a sharp dose fall-
off outside high dose regions, and it avoids underdosage of the target in “easy”
scenarios. The method shares the benefits of the previous scenario-based ro-
bust planning methods over geometric margins for applications where the static
dose cloud approximation is inaccurate, such as irradiation with few fields and
irradiation with ion beams. These properties are demonstrated on a suite of
phantom cases planned for treatment with scanned proton beams subject to
systematic setup uncertainty.
1. Introduction
Safety margins are the most utilized means of generating radiation therapy treatment
plans that are robust against errors. For instance, to mitigate the risk that the target
is located differently during the plan delivery than during the image acquisition, a
planning target volume (PTV) is usually defined as a geometric expansion of the
clinical target volume (CTV), and planning is performed to deliver high dose to the
full PTV. Analogously, the uncertainty in the position of an organ at risk (OAR) can
be mitigated by an expansion into a planning organ-at-risk volume (PRV). Recipes
for the calculation of margins on the basis of systematic and random uncertainties
and the amplitude of respiration are surveyed in van Herk [21].
An underlying assumption when geometric margins are used is that the static
dose cloud approximation is accurate. According to this approximation, the patient is
moving (as an effect of the errors) inside a static dose distribution that is not affected
by the motion [19]. This approximation is often sufficiently accurate for tumors in
regions of relatively homogeneous density, such as cancers in the pelvic region [4].
The approximation is, however, inaccurate for sites of heterogeneous density, such
as lung, which can lead to under- or overdosage if the colocation of the target and
the treatment fields differs from what was planned [4]. The approximation is also
inaccurate for treatments with few fields, because it does not model that a setup shift
in parallel with a beam axis only affects the corresponding beam dose marginally
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2(mainly by scaling according to the inverse-square law), whereas perpendicular shifts
affect the beam dose to a large extent (because the dose is displaced). The situation
is aggravated for ion treatments, the depth-dose curves of which are more sensitive to
the density distribution of the treated volume than those of photon treatments [13].
As alternatives to geometric margins, methods that take uncertainties into ac-
count explicitly in the optimization have been proposed [8, 16, 19, 20]. In these
methods, dose distributions for multiple error scenarios (e.g., setup shifts, scaled
densities, or displaced organs) are computed and the treatment plans are optimized
with respect to all of these doses simultaneously. The methods differ in how they
take the dose distributions into account: expected value optimization [19, 20] mini-
mizes the expectation of the objective value over the scenario doses, composite worst
case optimization [8] minimizes the objective value of the worst case scenario, and
voxelwise worst case optimization [16, 20] minimizes the objective function applied
to a worst case dose distribution defined as the worst scenario dose to each voxel con-
sidered independently. While these methods can produce robust plans also for sites
of heterogeneous density, they result in qualitatively different plans than margin-
based planning, even in situations where the static dose cloud approximation holds.
The differences are not always desirable [6, 7]: expected value optimization pro-
tecting against systematic errors results in gradual dose fall-offs, something that
only marginally increases the probability of tumor control but still results in highly
increased integral dose; composite worst case optimization risks neglecting “easy”
scenarios; and voxelwise worst case optimization does not utilize that an increased
dose and the periphery of the high-dose region leads to a steeper dose gradient
against the non-involved tissue and is overly conservative when used in combination
with dose-volume histogram (DVH) goals, because it considers an unphysical dose
distribution.
In the present paper, we introduce a generalization of margin-based planning.
The generalization is scenario-based, but does not suffer from the disadvantages
mentioned above. When the static dose cloud approximation is exact, our method
is equivalent to planning with geometric margins. However, the method can also be
used to achieve robust plans when the static dose cloud approximation is inaccurate.
Because the static dose cloud approximation is implicitly assumed with the use of
geometric margins, this implies that our method is a generalization of treatment
plan optimization with margins.
2. Methods
We generalize the concept of treatment plan optimization with margins to the case
when scenario doses are computed for multiple scenarios. The following exposition
concerns a single CTV subject to setup errors, but the method can be readily ap-
plied to multiple regions of interest (ROIs), including OARs. For simplicity of the
presentation, it is assumed that all setup error scenarios correspond to geometric
shifts that can be represented by vectors with all components being multiples of the
voxel dimensions, and that the voxels of the considered ROI lines up with the dose
grid.
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The exposition is structured as follows: We first highlight that the use of margins
entails the implicit assumption that the static dose cloud approximation holds. We
then show how a voxel-separable plan evaluation criterion applied to a PTV can be
reformulated as a criterion applied to the CTV under multiple scenarios with scenario
doses given by the static dose cloud approximation. Using this reformulation, we
define a scenario-based criterion that utilizes the true, non-approximate, scenario
doses—this is the scenario-based generalization of margins. Finally, we give a number
of possible refinements of this criterion and discuss how to adapt the method to other
criteria than directly voxel-separable ones.
2.1. Margins implicitly assume the static dose cloud approximation
Target margins are generally defined using a geometric expansion of the CTV, and
planning is performed to deliver high dose to the PTV, which is the union of the
CTV and the margin [10, Section 4.5]. The size of the PTV is selected so that the
probability that the CTV will be within the PTV is high [23]. For this to imply
a high probability of the CTV receiving a high dose—which is the ultimate goal
of the use of a margin—the static dose cloud approximation must be reasonably
accurate: If it is, then whenever the CTV displaced by the errors is geometrically
within the PTV, it will receive a high dose. If the approximation on the other hand
is inaccurate, meaning that the dose might deform as an effect of the displacement,
then there are no guarantees regarding the dose received by the moving CTV. This
is the reason behind the failure of geometric margins in highly modulated proton
therapy [8, 13].
2.2. A scenario-based reformulation of margins
We consider an arbitrary plan evaluation criterion that is additively separable over
the voxels. Let the voxelwise component of the criterion be given by the function φ.
Applied to the PTV, the criterion takes the form∑
i∈P
φ(di), (2.1)
where di is the dose to voxel i and P an index set over the PTV voxels. Common
voxel-separable criteria include minimum, maximum, and uniform dose penalties,
see, e.g., Oelfke and Bortfeld [15].
According to the static dose cloud approximation, the effect of a setup error
is that the patient is shifted rigidly inside a static dose distribution [19]. A rigid
shift of the patient corresponds to the voxel indices being shifted by a fixed offset
(assuming that the shift lines up with the dose grid). Let S denote the set of
scenarios and let the offset corresponding to the shift s, for s in S, be denoted by
j(s). The CTV voxels under scenario s are then given by the scenario-dependent
set C(s) := {i+ j(s) : i ∈ C}, where C enumerates the CTV voxels in the nominal
scenario (corresponding to no error). Because the PTV is an expansion of the CTV,
it holds that P = ∪s∈SC(s) if S is appropriately defined, as illustrated in Figure 1.
The criterion (2.1) can thus be equivalently stated as
4CTV
PTV
(a) A patient with a CTV
and a PTV.
(b) The dashed ellipses il-
lustrate C(s) = {i + j(s) :
i ∈ C} for two scenarios s.
(c) The set ∪s∈SC(s) ap-
proaches P as the number
of scenarios increases.
Figure 1. Construction of the PTV from translated copies of the CTV.
∑
i∈
⋃
s∈S C(s)
φ(di).
This expression, in turn, is equivalent to∑
s∈S
∑
i∈C(s)
piφ(di),
where pi is the reciprocal of the number of scenarios s under which voxel i is in C(s):
pi = 1/ |{s ∈ S : i ∈ C(s)}| ,
where | · | denotes the cardinality of a set, see Figure 2.
pi = 1/2
Figure 2. Voxel i has weight pi = 1/2 because it is contained in C(s) (dashed ellipses)
under two scenarios s.
Offsetting the voxel indices within a fixed dose distribution is equivalent to keep-
ing the voxel indices fixed but shifting the dose rigidly. The criterion can therefore
also be formulated as ∑
s∈S
∑
i∈C
pi+j(s)φ(di+j(s)).
Let d˜i(s) := di+j(s) denote the dose to voxel i under scenario s and pi,s := pi+j(s)
denote the corresponding weight. The criterion can then be written as∑
s∈S
∑
i∈C
pi,sφ(d˜i(s)), (2.2)
which is our scenario-based reformulation of the PTV criterion.
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In summary, we have derived the following equivalence:
∑
i∈P
φ(di) =
∑
s∈S
∑
i∈C
pi,sφ(d˜i(s)), (2.3)
where d˜i(s) = di+j(s) and
pi,s = 1/
∣∣{s′ ∈ S : i+ j(s)− j(s′) ∈ C}∣∣ , (2.4)
and S has been selected such that P = {i+ j(s) : i ∈ C, s ∈ S}.
2.3. The scenario-based generalization of margins
The expression (2.2) provides a reformulation of the criterion (2.1) for the PTV to
a scenario-based criterion for the CTV. The static dose cloud approximation was
used to define the weights pi,s and the dose distribution d˜(s). We propose the use
the scenario-based criterion (2.2) together with the exact dose distribution (or a
more accurate approximation than the static dose cloud approximation) of scenario
s, denoted by d(s), in place of the dose distribution d˜(s) estimated by the static dose
cloud approximation. In cases where the static dose cloud approximation holds,
this means that our formulation will be equivalent to using a PTV; in cases where
the static dose cloud approximation does not hold, our formulation provides a novel
scenario-based robust planning method.
2.4. Beam-specific effects
The static dose cloud approximation does not model that the effect of an error
can vary with the beams. Such variations can, however, be incorporated in the
calculation of the weights pi,s by the definition of weights p
(b)
i,s for each beam b in
the set B of all beams, for all voxels i and scenarios s. The weights p(b)i,s are under
this refinement defined according to (2.4), but with j(b) substituted for j, where
j(b)(s) is the offset in the dose grid corresponding to the shift of scenario s projected
onto the beam plane of beam b. Thus, j(b)(s) neglects setup errors that are parallel
to the beam axis, as illustrated in Figure 3. The weights for different beams are
combined into a single weight pi,s by interpolation that takes into account the dose
contribution to voxel i under scenario s from each beam. Let d
(b)
i (s) denote the dose
of beam b delivered to voxel i under scenario s. Then, the beam-specific counterpart
of the criterion (2.2) takes the form
∑
s∈S
∑
i∈C
φ(di(s))
∑
b∈B
d
(b)
i (s)
di(s)
p
(b)
i,s , (2.5)
where d
(b)
i (s)/di(s) is taken as 1/|B| whenever di(s) = 0.
6(a) C(s) under the scenarios s in
S .
(b) C(s) projected onto the
beam plane for the beam along
the x-axis.
(c) C(s) projected onto
the beam plane for the
beam along the y-axis.
Figure 3. Projection of C(s) (dashed ellipses) onto the beam planes. The projected
sets are used in the calculation of beam-specific weights, but φ is still evaluated using
the scenario doses without projections.
2.5. Extensions to other types of criteria
The reformulation (and consequently generalization, when d is substituted for d˜) of
margins can be extended to other types of criteria than additively voxel-separable
functions, as the following examples show: For a criterion that is a function ψ of an
additively voxel-separable function, such as equivalent uniform dose measures [14],
application of ψ to the left- and right-hand side of (2.3) yields the following refor-
mulation:
ψ
(∑
i∈P
φ(di)
)
= ψ
(∑
s∈S
∑
i∈C
pi,sφ(d˜i(s))
)
.
Another common form of criteria are multiplicatively voxel-separable functions. Cri-
teria of this type include tumor control probabilities, because the overall probability
of tumor control is the product of the probability for tumor control in each tumor
voxel. Derivations analogous to those in Section 2.2 yield the following reformulation
for multiplicatively voxel-separable functions:∏
i∈P
φ(di) =
∏
s∈S
∏
i∈C
φ(d˜i(s))
pi,s . (2.6)
For a criterion of the form of a function ψ of a multiplicatively voxel-separable func-
tion, such as a normal tissue complication probability calculated using the relative
seriality model [11], a reformulation is possible by application of ψ to the left- and
right-hand side of (2.6). Finally, a constraint for all voxels i in P is equivalent to a
constraint for all voxels i in C(s) and scenarios s in S.
2.6. Experimental study
2.6.1. Optimization formulations and phantom geometries
We assessed the scenario-based generalization of margins by comparison against ge-
ometric margins and against previously published scenario-based robust planning
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methods. The scenario-based methods that we used for benchmark were (compos-
ite) worst case optimization and expected value optimization [6, Sections II.D.1–2].
The comparison was performed with respect to stylized phantom geometries in either
one dimension (1D) or two dimensions (2D), which contained a CTV with voxels enu-
merated by the set C and, for a subset of the cases, an OAR with voxels enumerated
by the set O. The geometries were planned for treatment with either a single orthog-
onal proton beam (incident from a dimension orthogonal to the patient geometry)
or two coplanar proton beams at a perpendicular angle to each other. Treatment
plan optimization using the various methods to achieve robustness was performed
with respect to an objective function f penalizing deviation from a uniform dose of
one to the CTV and a dose of zero elsewhere, according to
f(d) = wC
∑
i∈C
vi,C(di − 1)2 + wO
∑
i∈O
vi,Od
2
i + wE
∑
i∈E
vi,Ed
2
i .
Here, E enumerates all voxels inside the external contour while for a general structure
R, vi,R is the fraction of the structure that is contained in voxel i (this weight is used
to take into account that the ROIs do not necessarily line up with the dose grid),
and wR is a scalar importance weight. Isotropic setup uncertainty of 1 cm was taken
into account in the optimization. A total of four combinations of geometry, beam
arrangement, and objective function were considered, which we labeled Examples
1–4, see Table 1.
The examples were selected to clearly exhibit the differences between the meth-
ods, and the methods are not necessarily intended to be used for such formulations:
For example, the worst case optimization method is not intended to be applied to
hopelessly conflicting scenarios, as in Examples 3 and 4. In such cases, a different
set of scenarios should ideally be selected for the method to yield the desired result.
Moreover, as explained for worst case optimization methods in a previous study [7],
the methods are identical when there are no conflicts.
Table 1. Beam arrangement, structure definition, and objective function weights for
the example cases. All intervals are specified in centimeters.
Example Beam(s) C O E wC wO wE
1 Orthogonal [−2, 2] – [−6, 6] 10 – 1
2 Coplanar
[−32 , 32]2 – [−6, 6]2 100 – 1
3 Orthogonal
[−32 , 32]2 [−5,−3]× [−2, 2] [−6, 6]2 100 100 1
4 Orthogonal
[−32 , 32]2 [−4,−2]× [−2, 2] [−6, 6]2 100 20 1
2.6.2. Numerical optimization and dose calculation
Proton beams were represented by scanning spots selected such that a Bragg peak
position matched the voxel center for each voxel in the dose grid within 2 cm of
the CTV. Spot doses for orthogonal beams were calculated using a Gaussian point-
spread function with a standard deviation of 3 mm. Spot doses for coplanar beams
8were calculated using the analytic proton depth-dose curve in Bortfeld [2]. The dose
calculations were performed in a grid with a voxel side length of 1 mm. The set
of possible setup shifts S was represented by 19 uniformly distributed scenarios in
1D (Example 1) and by nine scenarios (the nominal scenario, all shifts of 1 cm in
the positive and negative axis directions, and all pairwise combinations of the axis
directions) in 2D (Examples 2–4). A shift was modeled as a rigid translation of the
beam isocenters relative to the patient coordinate system. The spot weights were
optimized subject to nonnegativity bounds using the nonlinear programming solver
SNOPT v7.2 (Stanford Business Software, Palo Alto, California).
Treatment plan optimization using scenario-based margins was implemented on
the beam-specific form of Section 2.4 for the beam arrangement with two fields
(Example 2). Optimization using geometric margins was implemented as mini-
mization of the objective function value in the nominal scenario evaluated with
respect geometrically expanded structures. The CTV was expanded to a PTV and
the OAR expanded to a PRV by substitution of an expanded volume defined as
{i+ j(s) : i ∈ R, s ∈ S} for the original structure R. The objective function weights
were scaled with a factor equal to the fractional increase in volume due to the ex-
pansion in order to obtain comparable results with the scenario-based methods. The
maximum operator used to compute the worst case objective function value in the
worst case optimization was approximated by a smooth power mean according to
max
s∈S
f(d(s)) ≈
(
1
|S|
∑
s∈S
f(d(s))10
)1/10
in order for the operator to be continuously differentiable. The expected objective
function value used in the expected value optimization was calculated with respect
to normally distributed errors with standard deviation selected such that 95% of all
values were contained within 1 cm, conditioned on that an error of at most 1 cm
would occur.
3. Results
Doses are quantified in percent of the prescription. We use the term “margins” to
refer both geometric and scenario-based margins when their results are similar.
3.1. Example 1
This example compares the previous scenario-based methods against margins under
very simple conditions: the static dose cloud approximation is exact and there is no
OAR that competes with target coverage. The results for geometric and scenario-
based margins coincided precisely.
Figure 4 shows that all methods gave a uniform dose of about 97% to the inner-
most 2 cm of the CTV. Margins kept the planned dose uniform at this level inside
the entire PTV, except for at the very edges where the dose was increased to form
“shoulders.” Worst case optimization created a mildly decreasing dose with increas-
ing distance to the origin outside the innermost 2 cm of the CTV. Like margins, it
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created shoulders at the edges of the high-dose region. Expected value minimization
created a smooth and gradual fall-off to a dose of about 30% at the edges of the
PTV, without any shoulder formations.
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Figure 4. Nominal doses for Example 1. The height of the CTV and PTV indicates
the prescription dose.
3.2. Example 2
This example highlights the differences between the scenario-based methods and
geometric margins if the static dose cloud approximation is inaccurate. The reason
that the static dose cloud approximation gives a poor prediction of a perturbed dose
is that the beam doses are unaffected by components of the shifts that are parallel to
the beam axis (neglecting the small effect that the beam doses are scaled according
to the inverse-square law).
Figure 5 depicts the nominal dose for scenario-based and geometric margins.
Associated DVHs for all scenarios are shown in Figure 6. Corresponding results
are not shown for worst case and expected value optimization because of the close
similarity with scenario-based margins. However, line doses for all methods are
depicted in Figure 7. Geometric margins covered the PTV with a uniform dose at the
prescription level. The scenario-based methods instead created a linearly decreasing
dose from 100% at the CTV edge to 90% at the proximal edge of the PTV and
to about 70% at the distal edge of the PTV. The CTV dose of the scenario-based
methods was despite the lower integral dose uniform around 100% in all scenarios,
whereas the CTV dose varied in the range 90–135% for geometric margins. The beam
doses in Figure 8 explain why the plan created by geometric margins is sensitive to
perturbations: The saddle-shaped doses (peaks on the lateral edges of the CTV and
valleys on the proximal and distal edges) sum to a highly uniform total dose with
a steep fall-off in the nominal scenario, but the total dose is irregular if the beams
do not patch as intended. The scenario-based methods created uniform beam doses
that do not rely on that the beams patch accurately.
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(a) Geometric margins (b) Scenario-based margins
Figure 5. Nominal doses for Example 2. The CTV is indicated by a solid line and
the PTV is indicated by a dashed line.
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(a) Geometric margins
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(b) Scenario-based margins
Figure 6. DVHs for Example 2 in all scenarios.
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Figure 7. Line dose profiles for Example 2 in the nominal scenario for a trace along
the x-axis through the isocenter.
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(a) Geometric margins (b) Scenario-based margins
Figure 8. Beam doses for Example 2 for the beam along the x-axis. The beam doses
for the beam along the y-axis were identical except for a 90◦ rotation. The CTV is
indicated by a solid line and the PTV is indicated by a dashed line.
3.3. Example 3
The purpose of this example is to investigate how scenario-based margins handle a
situation when target coverage in some scenarios is incompatible with OAR sparing.
The incompatibility stems from that the PTV overlaps with the PRV. The static
dose cloud approximation is close to exact: it would have been exact had it not been
for shift scenarios in pairwise combinations of the axis direction that do not line up
exactly with the dose grid. The results for geometric margins were, nevertheless,
highly similar to the results for scenario-based margins (98% of the differences in
voxel dose were less than 3% of the prescription) and are therefore not shown.
Figure 9 shows that margins and expected value optimization extended the high-
dose region from the CTV to the edges of the PTV except for in the leftward direction
that is in conflict with the OAR. The CTV coverage was therefore maintained under
all shifts without rightward component. Coverage was lost almost completely for
20% of the CTV under rightward shifts, see Figure 10. A minor difference for
expected value optimization compared to margins was that the doses in the CTV-
to-PTV margin were slightly lower and the dose fall-off was more gradual. Worst
case optimization only extended the high-dose region to the right of the CTV. The
CTV coverage was therefore poor not only under the rightward shifts that are in
conflict with OAR sparing, but also under the relatively “easier” up- and downward
shifts. The line doses in Figure 11 demonstrate how the high-dose region for worst
case optimization was retracted in the up- and downward directions compared to
the other methods.
3.4. Example 4
The difference between this example and Example 3 is that the PRV overlaps with
the CTV and the weight on the OAR objective is five times smaller than previously.
The results for geometric margins are not depicted because of close similarity with
the results for scenario-based margins (98% of the differences in voxel dose were less
than 3% of the prescription).
The lesser priority on OAR sparing compared to Example 3 made margins accept
a dose of about 80% in the overlap region between the PTV and PRV, see Figure 12.
The dose compromise in this region was controlled in the sense that the dose was
12
(a) Scenario-based margins (b) Worst case optimization (c) Expected value optimization
Figure 9. Nominal doses for Example 3. The CTV and OAR are indicated by solid
lines and the PTV and PRV are indicated by dashed lines.
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(a) Scenario-based margins
Dose (% of the prescription)
0  20  40  60  80  100  
Vo
lu
m
e 
(%
)
0
 
20
 
40
 
60
 
80
 
100
CTV
OAR
(b) Worst case optimization
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(c) Expected value optimization
Figure 10. DVHs for Example 3 in all scenarios.
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Figure 11. Line dose profiles for Example 3 in the nominal scenario for a trace
along the y-axis through the isocenter. The height of the CTV and PTV indicates
the prescription dose.
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uniform, except for peaks in the dose at the left edge of the PTV. Worst case opti-
mization gave a uniform dose at the prescription level to the CTV in the left shift
scenario, and underdosed the CTV to about 70% in the region where it overlaps with
the PRV. The CTV coverage was poor also under all shifts with an up- or downward
component because there was little extension of the high-dose region outside the
CTV in these directions, see Figure 13. Expected value optimization covered almost
the entire CTV with a dose of one in the nominal scenario, thereby accepting doses
above 90% to more than 20% of the OAR if a leftward shift occurs. The CTV dose
was highly non-robust to shifts in the right direction because the dose falls gradually
towards zero left of the CTV edge, see Figure 14. The CTV coverage under a shift
with leftward component was comparable to margins.
(a) Scenario-based margins (b) Worst case optimization (c) Expected value optimization
Figure 12. Nominal dose distributions for Example 4. The CTV and OAR are
indicated by solid lines and the PTV and PRV are indicated by dashed lines..
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(a) Scenario-based margins
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(b) Worst case optimization
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(c) Expected value optimization
Figure 13. DVHs for Example 4 in all scenarios.
4. Discussion
4.1. Advantages over geometric margins
There is clear evidence that scenario-based optimization can provide better target
coverage robustness than margins and also reduce the dose to healthy tissues if the
static dose cloud approximation is inaccurate [3,6,8,12]. Scenario-based optimization
is therefore particularly advantageous for ion therapy, treatments of heterogeneous
densities, and treatments with few fields. Our results for Example 2 reinforce this
conclusion: geometric margins created nonuniform beam doses that were sensitive
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Figure 14. Line dose profiles for Example 4 in the nominal scenario for a trace
along the x-axis through the isocenter. The height of the CTV and PTV indicates
the prescription dose. The OAR and PRV boundaries are indicated by vertical lines.
to perturbations and placed more dose inside the CTV-to-PTV margin than neces-
sary, while all scenario-based methods created highly robust plans. Furthermore, a
potential advantage of scenario-based methods, even if scenario doses are calculated
using the static dose cloud approximation, is that robustness can be implemented for
nonuniform CTV prescriptions, as in dose-painting guided by functional imaging [1].
4.2. Advantages over other scenario-based models
4.2.1. Dose gradients
This study, alongside previous data [6], shows that expected value optimization with
respect to systematic setup uncertainty can lead to doses that fall gradually from
the prescription level to a dose of zero over a prolonged distance outside the CTV.
Such a gradual fall-off was observed consistently in Examples 1, 3, and 4. Margins
and worst case optimization instead created dose shoulders at the PTV boundary
that contributed to a steep fall-off. The gentle fall-off created by expected value
optimization is a point of concern in view of the fact that the possibility to deliver
dose-escalated treatments without compromising the dose to surrounding organs has
been a key driver in the adoption of intensity-modulated over conformal radiation
therapy [17]: van Herk et al. [22] showed that steep dose gradients are necessary
for such dose escalation. Proponents of proton therapy also often point to the steep
fall-off on the lateral and distal edge of the target as evidence of its superiority over
photon treatments [18].
4.3. Tradeoffs between conflicting criteria
In a previous study [7], we showed that worst case optimization can be too conser-
vative if target coverage to some extent is incompatible with sparing of an OAR.
The optimization can then neglect coverage also in scenarios that are not in direct
conflict with the OAR. This effect was also apparent in Examples 3 and 4, where
worst case optimization disregarded CTV coverage with respect to shifts with an up-
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or downward component. Margins and expected value optimization did not exhibit
this shortcoming. These methods instead created robust CTV coverage for all shifts
except those that required an extension of the high-dose region into the PRV. For the
worst case optimization method to work as intended, the scenarios of non-resolvable
conflict could be retracted.
Margins and expected value optimization exhibited markedly different behaviors
with respect to the dose compromise in the overlap region between the PTV and
PRV in Example 4. Margins created a controlled underdosage of the CTV while
expected value optimization sacrificed CTV coverage under a rightward shift and
OAR sparing under a leftward shift. This is an effect of that the nominal scenario
has a larger probability of occurring than the shift scenarios. Furthermore, the
results for expected value optimization depend on the scenario discretization: The
probability for the extreme shift scenarios become smaller if intermediate shifts are
also incorporated in the uncertainty set S due to normalization of the discretized
probabilities.
It is a clinical decision whether the characteristics of margins or expected value
optimization are preferable. The current ICRU guidelines advocate that when the
PTV and OAR or PRV overlap, priority rules should be used, or the regions should
be subdivided into regions with different absorbed-dose constraints [10, Section 4.5].
This effect is achieved by margin-based planning with importance weights for the
PTV and the OAR or PRV used in the optimization. Several clinical protocols,
however, prescribe a smaller margin in the interface against some radiation sensitive
structures, for example a retracted CTV-to-PTV margin for prostate in the posterior
direction to promote rectal sparing [5, 24]. It is our view that if a retraction is to
be made in a scenario-based model, it should be incorporated in the selection of
scenarios rather than in their probabilities, in order to maintain steep dose gradients.
Optimization of the definition of the uncertainty set S subject to constraints that
a set of clinical goals is satisfied for all scenarios in S is described in Fredriksson et
al. [9].
4.4. Potential disadvantages
4.4.1. Nonconvexity
The scenario-based margins lead to a nonconvex optimization model if beam-specific
effects are taken into account, as shown in Appendix A. Nonconvex optimization
problem can have multiple local minima, meaning that optimization algorithms can-
not guarantee convergence to the global optimum. While a nonconvex formulation
allows the existence of multiple local optima, however, it does not assure that such
optima exist. The local optima may also be of negligible clinical difference even if
they do exist.
4.4.2. Limitation to setup errors in homogeneous media
The beam-specific form of the scenario-based margins does not take the mass density
of the treatment volume into account in the calculation of the beam-, scenario- and
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voxel-specific weights. The model is therefore appropriate for treatments with few
fields, as demonstrated by Example 2, but although the correct scenario doses are
used, the weights may be inappropriate for irradiation of heterogeneous media. The
scenario-based margins as presented here are also not designed for handling of ion
beam range errors, and cannot utilize multiple patient images for handling of inter-
and intra-fraction organ motion. Extensions to these types of uncertainty will be
presented in a separate publication.
5. Conclusions
We have introduced a scenario-based generalization of treatment plan optimization
with margins to handle setup uncertainties. When the static dose cloud approxima-
tion is exact, the generalization is equivalent to margins, but when the approximation
is inaccurate, the generalization exhibits the benefits of scenario-based optimization.
Comparative planning on phantom geometries demonstrated that the scenario-based
margins can provide robustness where geometric margins fail and at the same time
avoid some disadvantages of previous methods for robust planning, such as the un-
necessarily gentle dose fall-off of expected value optimization and the neglection of
“easy” scenarios of worst case optimization.
A. Proof of nonconvexity
The following example shows that a beam-weighted criterion f defined according
to (2.5) can be nonconvex even when φ is convex. Consider a 2D geometry where a
single voxel is irradiated by a first beam along the x-axis and a second beam along
the y-axis. Let φ(d) = |d|3/2 and let S be an uncertainty set composed of the nominal
scenario and a 1-voxel shift along the y-axis. The beam- and scenario-specific weights
then take on the values p
(1)
s = 1 and p
(2)
s = 1/2 for all s in S. Consider two plans A
and B with beam doses according to
d
(b)
A
(s) =
{
2 if b = 1
0 otherwise
and d
(b)
B
(s) =
{
4 if b = 2
0 otherwise
, ∀s ∈ S.
Convexity of f requires that the function value of the average dose is less than or
equal to the average function value. The inequality
f((dA + dB)/2) = 4
√
3 > (f(dA) + f(dB))/2 = 2(
√
2 + 2),
therefore, proves the nonconvexity of f .
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